ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma
Purpose. To investigate the expression of LPCAT1 in liver hepatocellular carcinoma (LIHC) and its relationship with prognosis and immune infiltration and predict its upstream nonencoding RNAs (ncRNAs). Method. In this study, expression analysis and survival analysis for LPCAT1 in pan cancers were fi...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/1584397 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832565817481363456 |
---|---|
author | Qiu Sun Xudong Liu Qunlong Peng Lei Hu Xiaochun Jiang |
author_facet | Qiu Sun Xudong Liu Qunlong Peng Lei Hu Xiaochun Jiang |
author_sort | Qiu Sun |
collection | DOAJ |
description | Purpose. To investigate the expression of LPCAT1 in liver hepatocellular carcinoma (LIHC) and its relationship with prognosis and immune infiltration and predict its upstream nonencoding RNAs (ncRNAs). Method. In this study, expression analysis and survival analysis for LPCAT1 in pan cancers were first performed by using The Cancer Genome Atlas (TCGA) data, which suggested that LPCAT1 might be a potential LIHC oncogene. Then, ncRNAs contributing to the overexpression of LPCAT1 were explored in starBase by a combination of expression analysis, correlation analysis, and survival analysis. Immune cell infiltration of LPCAT1 in LIHC was finally investigated via Tumor Immune Estimation Resource (TIMER). Result. SNHG3 was observed to be the most promising upstream lncRNA for the hsa-miR-139-5p/LPCAT1 axis in LIHC. In addition, the LPCAT1 level was significantly positively associated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression in LIHC. Conclusion. To summarize, the upregulation of LPCAT1 mediated by ncRNAs is associated with poor prognosis, immune infiltration, and immune checkpoint expression in LIHC. |
format | Article |
id | doaj-art-d0234b7498e04d9c999fd1530e745c77 |
institution | Kabale University |
issn | 2314-7156 |
language | English |
publishDate | 2022-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Immunology Research |
spelling | doaj-art-d0234b7498e04d9c999fd1530e745c772025-02-03T01:06:35ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/1584397ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular CarcinomaQiu Sun0Xudong Liu1Qunlong Peng2Lei Hu3Xiaochun Jiang4Heilongjiang University of Chinese MedicineHeilongjiang University of Chinese MedicineCollege of PharmacyAnhui Medical UniversityHeilongjiang University of Chinese MedicinePurpose. To investigate the expression of LPCAT1 in liver hepatocellular carcinoma (LIHC) and its relationship with prognosis and immune infiltration and predict its upstream nonencoding RNAs (ncRNAs). Method. In this study, expression analysis and survival analysis for LPCAT1 in pan cancers were first performed by using The Cancer Genome Atlas (TCGA) data, which suggested that LPCAT1 might be a potential LIHC oncogene. Then, ncRNAs contributing to the overexpression of LPCAT1 were explored in starBase by a combination of expression analysis, correlation analysis, and survival analysis. Immune cell infiltration of LPCAT1 in LIHC was finally investigated via Tumor Immune Estimation Resource (TIMER). Result. SNHG3 was observed to be the most promising upstream lncRNA for the hsa-miR-139-5p/LPCAT1 axis in LIHC. In addition, the LPCAT1 level was significantly positively associated with tumor immune cell infiltration, biomarkers of immune cells, and immune checkpoint expression in LIHC. Conclusion. To summarize, the upregulation of LPCAT1 mediated by ncRNAs is associated with poor prognosis, immune infiltration, and immune checkpoint expression in LIHC.http://dx.doi.org/10.1155/2022/1584397 |
spellingShingle | Qiu Sun Xudong Liu Qunlong Peng Lei Hu Xiaochun Jiang ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma Journal of Immunology Research |
title | ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma |
title_full | ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma |
title_fullStr | ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma |
title_full_unstemmed | ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma |
title_short | ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma |
title_sort | ncrna mediated high expression of lpcat1 correlates with poor prognosis and tumor immune infiltration of liver hepatocellular carcinoma |
url | http://dx.doi.org/10.1155/2022/1584397 |
work_keys_str_mv | AT qiusun ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma AT xudongliu ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma AT qunlongpeng ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma AT leihu ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma AT xiaochunjiang ncrnamediatedhighexpressionoflpcat1correlateswithpoorprognosisandtumorimmuneinfiltrationofliverhepatocellularcarcinoma |